FGF19 promotes progression of prostate cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0045|75|10|1092-1101

ISSN： 0270-4137

Source： THE PROSTATE, Vol.75, Iss.10, 2015-07, pp. : 1092-1101

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

GOLM1 promotes prostate cancer progression through activating PI3K‐AKT‐mTOR signaling

By  

THE PROSTATE, Vol. 78, Iss. 3, 2018-02 ,pp. : 166-177

John Wiley & Sons Inc

Access to resources Recommend Favorite

Adipocyte‐derived monocyte chemotactic protein‐1 (MCP‐1) promotes prostate cancer progression through the induction of MMP‐2 activity

By  

THE PROSTATE, Vol. 75, Iss. 10, 2015-07 ,pp. : 1009-1019

John Wiley & Sons Inc

Access to resources Recommend Favorite

Methylselenocysteine preventing castration‐resistant progression of prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 1001-1008

John Wiley & Sons Inc

Access to resources Recommend Favorite

Operative Course of Transurethral Resection of the Prostate and Progression of Prostate Cancer

By  

Urologia Internationalis, Vol. 60, Iss. 3, 1998-06 ,pp. : 169-174

Karger

Access to resources Recommend Favorite

B7-H3 overexpression in pancreatic cancer promotes tumor progression

By                    

International Journal of Molecular Medicine, Vol. 31, Iss. 2, 2013-01 ,pp. : 283-291

Spandidos Publications

Access to resources Recommend Favorite